Mylan launches antifungal drug
PITTSBURGH — Mylan has launched a generic drug for treating fungal infections, the drug maker said Friday.
Mylan announced the launch of itraconazole capsules in the 100-mg strength. The drug is a generic version of Johnson & Johnson’s Sporanox, which is used to treat fungal infections that begin in the lungs blatsomycosis, histoplasmosis and aspergillosis in patients who are intolerant of or refractory to amphotericin B therapy. The drug also is used to treat fungal infections in the toenails and fingernails in patients without compromised immune systems.
The drug had sales of about $60 million during the 12-month period ended in March, according to IMS Health.
Save-A-Lot launches road trip marketing campaign
ST. LOUIS — Save-A-Lot, a hard-discount, limited-assortment grocery chain and a wholly owned subsidiary of Supervalu, kicked off its 2012 Fuel Your Family Road Trip in Orlando to raise awareness of Save-A-Lot stores as the go-to destination for affordable food.
Hitting the road for the 18-city, 30-day, 2,000-mile journey will be two Save-A-Lot brand ambassadors, Molly Stankovsky and Alex Frecon, both of Minneapolis, who won a national competition to serve as this year’s Fuel Your Family “Road Scholars.” They will travel through Florida, Georgia, South Carolina, North Carolina, Virginia, Washington D.C., Maryland, Pennsylvania and New York in a 2012 Subaru Outback to bring the brand to consumers as the summer road trip season winds down and the new school year gets underway.
Along the route, the Road Scholars will attend community events, conduct random acts of kindness, host customer appreciation events at Save-A-Lot stores, visit local Boys & Girls Clubs, and share recipes and tips for quick, easy and affordable meals. In addition, they will present donations from Save-A-Lot totaling $33,500 to local Feeding America affiliates, which will provide 268,000 meals to families in need. Save-A-Lot also will donate nearly 164,000 school supplies to benefit more than 18,000 students in Miami, Atlanta and Washington, D.C., and will donate $2,500 to the Juvenile Diabetes Research Foundation in Charlotte, N.C.
McKesson highlights Health Mart annual meeting during first-quarter conference call
SAN FRANCISCO — With the Supreme Court maintaining a status quo of sorts with regard to the Patient Protection and Affordable Care Act last month, retail pharmacy operators are going to need to continually drive efficiencies into their businesses, McKesson chairman and CEO John Hammergren noted during the wholesaler’s first-quarter conference call.
McKesson recently held its annual meeting for its independent pharmacy customers where more than just supply chain solutions were on display. "At the conference we highlighted solutions that helped independent pharmacists enhance patient loyalty and outcomes and broaden the range of services they provide," Hammergren said. "Solutions like McKesson’s sponsored clinical services network, which enables independent pharmacists to play a greater role in providing patient care and services, in addition to growing their revenues." Sponsored clinical services is a network of 13,000 community pharmacies delivering a suite of patient-centered programs, including education, support and behavioral coaching, he added. "The network streamlines the relationship between pharmacies, manufacturers and payer-sponsored programs focused on increasing adherence and improving patient care. Participating pharmacies benefit from the opportunity to increase customer loyalty, earn service fees and build their relationships with patients as a partner in their health care."
McKesson also is making available new social, Web and mobile technologies to help independents connect with their patients. "A significant number of attendees were Heath Mart pharmacy owners and pharmacists. With nearly 3,000 stores across the country, Health Mart has become the franchise model of choice for independent pharmacy owners looking to complement their local identity with a national brand," he said. "Health Mart continues to invest in new solutions to help these stores grow their business, including private label over-the-counter healthcare products and new consumer-facing web and mobile platforms."
McKesson on Thursday reported revenues of $30.8 billion, up 3%, for its first quarter ended June 30.
Distribution Solutions revenues were up 3% for the first quarter. U.S. pharmaceutical distribution revenues were up 4% for the first quarter, primarily reflecting market growth and new business with existing customers.
Medical-Surgical distribution and services revenues were up 9% for the first quarter.